Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.

Novel antibody-antibiotic conjugate eliminates intracellular S. aureus. Nature (2015) 2.04

Intracellular persisting Staphylococcus aureus is the major pathogen in recurrent tonsillitis. PLoS One (2010) 1.07

Activities of ceftobiprole and other cephalosporins against extracellular and intracellular (THP-1 macrophages and keratinocytes) forms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2009) 0.96

Cellular pharmacodynamics of the novel biaryloxazolidinone radezolid: studies with infected phagocytic and nonphagocytic cells, using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila. Antimicrob Agents Chemother (2010) 0.92

Intra- and extracellular activities of dicloxacillin and linezolid against a clinical Staphylococcus aureus strain with a small-colony-variant phenotype in an in vitro model of THP-1 macrophages and an in vivo mouse peritonitis model. Antimicrob Agents Chemother (2011) 0.86

Plectasin shows intracellular activity against Staphylococcus aureus in human THP-1 monocytes and in a mouse peritonitis model. Antimicrob Agents Chemother (2009) 0.83

Intra- and extracellular activities of dicloxacillin against Staphylococcus aureus in vivo and in vitro. Antimicrob Agents Chemother (2010) 0.82

Discovery and preclinical development of new antibiotics. Ups J Med Sci (2014) 0.80

Dissecting the mechanisms of linezolid resistance in a Drosophila melanogaster infection model of Staphylococcus aureus. J Infect Dis (2013) 0.79

Antimicrobial activity against intraosteoblastic Staphylococcus aureus. Antimicrob Agents Chemother (2015) 0.79

Therapy of intracellular Staphylococcus aureus by tigecyclin. BMC Infect Dis (2013) 0.78

Assessments of Thioridazine as a Helper Compound to Dicloxacillin against Methicillin-Resistant Staphylococcus aureus: In Vivo Trials in a Mouse Peritonitis Model. PLoS One (2015) 0.77

The immune response and antibacterial therapy. Med Microbiol Immunol (2014) 0.76

In vitro and in vivo efficacy of florfenicol for treatment of Francisella asiatica infection in tilapia. Antimicrob Agents Chemother (2010) 0.75

Humanized Mouse Models of Staphylococcus aureus Infection. Front Immunol (2017) 0.75

Fosfomycin enhances phagocyte-mediated killing of Staphylococcus aureus by extracellular traps and reactive oxygen species. Sci Rep (2016) 0.75

Bacterial biofilms: a common cause of persistent infections. Science (1999) 40.82

Staphylococcus aureus infections. N Engl J Med (1998) 36.39

Antibiotic resistance of bacteria in biofilms. Lancet (2001) 12.62

Exploitation of mammalian host cell functions by bacterial pathogens. Science (1997) 6.06

Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol (2006) 5.73

Antibiotic uptake by alveolar macrophages. J Lab Clin Med (1980) 4.69

Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis. Antimicrob Agents Chemother (2003) 3.76

Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) (2003) 3.66

Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin Infect Dis (1995) 3.49

Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol (2000) 3.08

Intracellular Staphylococcus aureus escapes the endosome and induces apoptosis in epithelial cells. Infect Immun (1998) 2.63

Is Staphylococcus aureus an intracellular pathogen? Trends Microbiol (2000) 2.31

Intracellular distribution and activity of antibiotics. Eur J Clin Microbiol Infect Dis (1991) 2.28

The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Clin Microbiol Infect (2006) 2.14

agr expression precedes escape of internalized Staphylococcus aureus from the host endosome. Infect Immun (2001) 2.11

Internalization of Staphylococcus aureus by cultured osteoblasts. Microb Pathog (1995) 2.03

Phagocytosis of Staphylococcus aureus by cultured bovine aortic endothelial cells: model for postadherence events in endovascular infections. Infect Immun (1986) 1.93

Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages. Antimicrob Agents Chemother (2006) 1.89

Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. J Infect Dis (1991) 1.89

MRSA--the tip of the iceberg. Clin Microbiol Infect (2006) 1.81

Penetration of antimicrobials into tissue culture cells and leucocytes. Scand J Infect Dis Suppl (1978) 1.65

Dicloxacillin and flucloxacillin: pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administration. Infection (1995) 1.61

A fatal case of necrotising pneumonia due to community-associated methicillin-resistant Staphylococcus aureus. Med J Aust (2007) 1.61

Influence of conversion of penicillin G into a basic derivative on its accumulation and subcellular localization in cultured macrophages. Antimicrob Agents Chemother (1987) 1.53

Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often? Postgrad Med J (2000) 1.49

Intracellular pharmacodynamics of antibiotics. Infect Dis Clin North Am (2003) 1.47

Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations. Antimicrob Agents Chemother (2002) 1.46

Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin. Antimicrob Agents Chemother (1995) 1.37

Increasing frequency of staphylococcal infective endocarditis. Experience at a university hospital, 1981 through 1988. Arch Intern Med (1990) 1.36

Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med (1999) 1.36

Survival and ultrastructural changes of Helicobacter pylori after phagocytosis by human polymorphonuclear leukocytes and monocytes. APMIS (1993) 1.30

Bacteremic Staphylococcus aureus spondylitis. Arch Intern Med (1998) 1.28

Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model. Antimicrob Agents Chemother (1996) 1.23

Biphasic intracellular expression of Staphylococcus aureus virulence factors and evidence for Agr-mediated diffusion sensing. Mol Microbiol (2003) 1.22

Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives. Curr Opin Drug Discov Devel (2006) 1.20

Intracellular Staphylococcus aureus. A mechanism for the indolence of osteomyelitis. J Bone Joint Surg Br (2003) 1.15

Influence of subinhibitory concentrations of penicillin, cephalothin, and clindamycin on Staphylococcus aureus growth in human phagocytic cells. Antimicrob Agents Chemother (1982) 1.14

Influence of P-glycoprotein inhibitors on accumulation of macrolides in J774 murine macrophages. Antimicrob Agents Chemother (2003) 1.14

Cellular pharmacokinetics and pharmacodynamics of the glycopeptide antibiotic oritavancin (LY333328) in a model of J774 mouse macrophages. Antimicrob Agents Chemother (2004) 1.10

Mechanisms of Staphylococcus aureus induced apoptosis of human endothelial cells. Apoptosis (2001) 1.08

Staphylococcus aureus endocarditis at a community teaching hospital, 1980 to 1991. An analysis of 106 cases. Arch Intern Med (1994) 1.07

Methicillin resistant Staphylococcus aureus versus methicillin sensitive Staphylococcus aureus adult haematogenous septic arthritis. Arch Orthop Trauma Surg (2007) 1.03

Intracellular survival of Staphylococcus aureus within cultured enterocytes. J Surg Res (2003) 1.02

Staphylococcus aureus bacteremia: compliance with standard treatment, long-term outcome and predictors of relapse. Scand J Infect Dis (2003) 0.99

Management of Staphylococcus aureus infections. Am Fam Physician (2005) 0.98

The treatment triangle for staphylococcal infections. N Engl J Med (2006) 0.97

Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo. Antimicrob Agents Chemother (1998) 0.96

Gelatinase B/MMP-9 as an inflammatory marker enzyme in mouse zymosan peritonitis: comparison of phase-specific and cell-specific production by mast cells, macrophages and neutrophils. Immunobiology (2007) 0.96

Treatment of hospital-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents (2007) 0.92

Effect of the MDR1 C3435T variant and P-glycoprotein induction on dicloxacillin pharmacokinetics. J Clin Pharmacol (2005) 0.88

Haematogenous Staphylococcus aureus meningitis. A 10-year nationwide study of 96 consecutive cases. BMC Infect Dis (2006) 0.86

Evaluation of antibiotic effectiveness against Staphylococcus aureus surviving within the bovine mammary gland macrophage. J Antimicrob Chemother (1988) 0.83

Modulation of efficacies and pharmacokinetics of antibiotics by granulocyte colony-stimulating factor in neutropenic mice with multidrug-resistant Enterococcus faecalis infection. J Antimicrob Chemother (2000) 0.81

Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis (2011) 6.08

Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveill (2015) 3.13

Pigs as source of methicillin-resistant Staphylococcus aureus CC398 infections in humans, Denmark. Emerg Infect Dis (2008) 2.52

Livestock-associated methicillin-resistant Staphylococcus aureus in humans, Europe. Emerg Infect Dis (2011) 2.35

Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med (2002) 2.24

Interplay in the selection of fluoroquinolone resistance and bacterial fitness. PLoS Pathog (2009) 2.21

Staphylococcus lugdunensis, a common cause of skin and soft tissue infections in the community. J Clin Microbiol (2009) 2.11

Whole genome sequencing identifies zoonotic transmission of MRSA isolates with the novel mecA homologue mecC. EMBO Mol Med (2013) 2.07

Rapid whole-genome sequencing for detection and characterization of microorganisms directly from clinical samples. J Clin Microbiol (2013) 1.86

Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence. PLoS One (2010) 1.77

Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography. Eur J Echocardiogr (2011) 1.72

Characteristics of Escherichia coli causing persistence or relapse of urinary tract infections: phylogenetic groups, virulence factors and biofilm formation. Virulence (2011) 1.64

Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis. J Antimicrob Chemother (2013) 1.60

Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections. J Antimicrob Chemother (2013) 1.56

In vivo transfer of the vanA resistance gene from an Enterococcus faecium isolate of animal origin to an E. faecium isolate of human origin in the intestines of human volunteers. Antimicrob Agents Chemother (2006) 1.55

Guidelines for reporting novel mecA gene homologues. Antimicrob Agents Chemother (2012) 1.54

Effect of generics on price and consumption of ciprofloxacin in primary healthcare: the relationship to increasing resistance. J Antimicrob Chemother (2010) 1.51

Comment on: withdrawal of growth-promoting antibiotics in Europe and its effects in relation to human health. Int J Antimicrob Agents (2007) 1.48

Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections. Antimicrob Agents Chemother (2005) 1.47

Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark. Microb Drug Resist (2008) 1.34

Effect of cold starvation, acid stress, and nutrients on metabolic activity of Helicobacter pylori. Appl Environ Microbiol (2002) 1.32

Capsule and fimbria interaction in Klebsiella pneumoniae. Infect Immun (2005) 1.30

High risk for nasal carriage of methicillin-resistant Staphylococcus aureus among Danish veterinary practitioners. Scand J Work Environ Health (2008) 1.27

Livestock origin for a human pandemic clone of community-associated methicillin-resistant Staphylococcus aureus. MBio (2013) 1.27

Broiler chickens, broiler chicken meat, pigs and pork as sources of ExPEC related virulence genes and resistance in Escherichia coli isolates from community-dwelling humans and UTI patients. Int J Food Microbiol (2010) 1.24

Tetracycline and macrolide co-resistance in Streptococcus pyogenes: co-selection as a reason for increase in macrolide-resistant S. pyogenes? Microb Drug Resist (2004) 1.23

Escherichia coli isolates from broiler chicken meat, broiler chickens, pork, and pigs share phylogroups and antimicrobial resistance with community-dwelling humans and patients with urinary tract infection. Foodborne Pathog Dis (2010) 1.18

Impact of bacteremia on the pathogenesis of experimental pneumococcal meningitis. J Infect Dis (2008) 1.18

Rapid differentiation between livestock-associated and livestock-independent Staphylococcus aureus CC398 clades. PLoS One (2013) 1.16

Changing epidemiology of pediatric Staphylococcus aureus bacteremia in Denmark from 1971 through 2000. Pediatr Infect Dis J (2007) 1.14

Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents. Antimicrob Agents Chemother (2008) 1.13

Detection of sul1, sul2 and sul3 in sulphonamide resistant Escherichia coli isolates obtained from healthy humans, pork and pigs in Denmark. Int J Food Microbiol (2005) 1.11

Diversity of the tetracycline resistance gene tet(M) and identification of Tn916- and Tn5801-like (Tn6014) transposons in Staphylococcus aureus from humans and animals. J Antimicrob Chemother (2009) 1.06

A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane. Antimicrob Agents Chemother (2010) 1.06

Danish integrated antimicrobial resistance monitoring and research program. Emerg Infect Dis (2007) 1.04

Antimicrobial, hemolytic, and cytotoxic activities of beta-peptoid-peptide hybrid oligomers: improved properties compared to natural AMPs. Chembiochem (2010) 1.03

Natural transfer of sulphonamide and ampicillin resistance between Escherichia coli residing in the human intestine. J Antimicrob Chemother (2008) 1.03

Helicobacter canis bacteraemia in a 7-month-old child. FEMS Immunol Med Microbiol (2007) 1.03

Development of a real-time quadruplex PCR assay for simultaneous detection of nuc, Panton-Valentine leucocidin (PVL), mecA and homologue mecALGA251. J Antimicrob Chemother (2012) 1.02

Meticillin-resistant Staphylococcus aureus (MRSA): screening and decolonisation. Int J Antimicrob Agents (2010) 1.01

A Case of Helicobacter cinaedi Bacteraemia in a Previously Healthy Person with Cellulitis. Open Microbiol J (2008) 1.01

Methicillin-resistant Staphylococcus aureus ST9 in pigs in Thailand. PLoS One (2012) 0.99

Polymorphic mutation frequencies in Escherichia coli: emergence of weak mutators in clinical isolates. J Bacteriol (2004) 0.98

Role of urinary cathelicidin LL-37 and human β-defensin 1 in uncomplicated Escherichia coli urinary tract infections. Infect Immun (2014) 0.97

Validation of FLEXICULT SSI-Urinary Kit for use in the primary health care setting. Scand J Infect Dis (2002) 0.97

Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia. Clin Infect Dis (2012) 0.97

Presence of methicillin-resistant Staphylococcus aureus in pigs in Peru. PLoS One (2011) 0.96

Influence of host genetics and environment on nasal carriage of staphylococcus aureus in danish middle-aged and elderly twins. J Infect Dis (2012) 0.95

Selection of resistant Streptococcus pneumoniae during penicillin treatment in vitro and in three animal models. Antimicrob Agents Chemother (2003) 0.94

Antimicrobial activities of twenty lysine-peptoid hybrids against clinically relevant bacteria and fungi. Chemotherapy (2008) 0.94

Influence of the blood bacterial load on the meningeal inflammatory response in Streptococcus pneumoniae meningitis. BMC Infect Dis (2006) 0.93

Intra- and extracellular activity of linezolid against Staphylococcus aureus in vivo and in vitro. J Antimicrob Chemother (2010) 0.93

Faecal Escherichia coli from patients with E. coli urinary tract infection and healthy controls who have never had a urinary tract infection. J Med Microbiol (2014) 0.93

Pig-associated methicillin-resistant Staphylococcus aureus: family transmission and severe pneumonia in a newborn. Scand J Infect Dis (2010) 0.93

Use of Vitek 2 antimicrobial susceptibility profile to identify mecC in methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2013) 0.92

Novel mutations in penicillin-binding protein genes in clinical Staphylococcus aureus isolates that are methicillin resistant on susceptibility testing, but lack the mec gene. J Antimicrob Chemother (2013) 0.92

Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model. J Antimicrob Chemother (2012) 0.92

Recurrent bacteraemia: A 10-year regional population-based study of clinical and microbiological risk factors. J Infect (2009) 0.92

Staphylococcus aureus ST398 detected in pigs in Australia. J Antimicrob Chemother (2014) 0.90

Efficacy of topical and systemic antibiotic treatment of meticillin-resistant Staphylococcus aureus in a murine superficial skin wound infection model. Int J Antimicrob Agents (2013) 0.90

Attenuation of the bacterial load in blood by pretreatment with granulocyte-colony-stimulating factor protects rats from fatal outcome and brain damage during Streptococcus pneumoniae meningitis. Infect Immun (2004) 0.89

Microarray-based detection of extended virulence and antimicrobial resistance gene profiles in phylogroup B2 Escherichia coli of human, meat and animal origin. J Med Microbiol (2011) 0.89

In vivo study of experimental pneumococcal meningitis using magnetic resonance imaging. BMC Med Imaging (2008) 0.89

Intracellular activity of the peptide antibiotic NZ2114: studies with Staphylococcus aureus and human THP-1 monocytes, and comparison with daptomycin and vancomycin. J Antimicrob Chemother (2010) 0.89

Virulence of Escherichia coli B2 isolates from meat and animals in a murine model of ascending urinary tract infection (UTI): evidence that UTI is a zoonosis. J Clin Microbiol (2010) 0.89

Rapid decay of Salmonella flagella antibodies during human gastroenteritis: a follow up study. J Microbiol Methods (2005) 0.89

Characterisation, dissemination and persistence of gentamicin resistant Escherichia coli from a Danish university hospital to the waste water environment. Environ Int (2007) 0.88

Rapid and high-resolution distinction of community-acquired and nosocomial Staphylococcus aureus isolates with identical pulsed-field gel electrophoresis patterns and spa types. Int J Med Microbiol (2013) 0.88

Fitness cost: a bacteriological explanation for the demise of the first international methicillin-resistant Staphylococcus aureus epidemic. J Antimicrob Chemother (2012) 0.88

Evaluation of a modular multiplex-PCR methicillin-resistant Staphylococcus aureus detection assay adapted for mecC detection. J Clin Microbiol (2013) 0.88

Virulence factors and phylogenetic grouping of Escherichia coli isolates from patients with bacteraemia of urinary tract origin relate to sex and hospital- vs. community-acquired origin. Int J Med Microbiol (2012) 0.88

Detection of clonal group A Escherichia coli isolates from broiler chickens, broiler chicken meat, community-dwelling humans, and urinary tract infection (UTI) patients and their virulence in a mouse UTI model. Appl Environ Microbiol (2010) 0.88

Vancomycin-resistant Enterococcus faecalis isolates from a Danish patient and two healthy human volunteers are possibly related to isolates from imported turkey meat. J Antimicrob Chemother (2008) 0.87

Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country. Microb Drug Resist (2011) 0.87

Penicillin resistance and serotype distribution of Streptococcus pneumoniae in Ghanaian children less than six years of age. BMC Infect Dis (2013) 0.87

Cerebral blood flow autoregulation in early experimental S. pneumoniae meningitis. J Appl Physiol (1985) (2006) 0.87

High cerebrospinal fluid (CSF) penetration and potent bactericidal activity in CSF of NZ2114, a novel plectasin variant, during experimental pneumococcal meningitis. Antimicrob Agents Chemother (2009) 0.86

Intra- and extracellular activities of dicloxacillin and linezolid against a clinical Staphylococcus aureus strain with a small-colony-variant phenotype in an in vitro model of THP-1 macrophages and an in vivo mouse peritonitis model. Antimicrob Agents Chemother (2011) 0.86

Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitis. J Neuroimmunol (2005) 0.86

Antimicrobial activity of peptidomimetics against multidrug-resistant Escherichia coli: a comparative study of different backbones. J Med Chem (2012) 0.86

Emergence of ampicillin-resistant Enterococcus faecium in Danish hospitals. J Antimicrob Chemother (2008) 0.86

The more antibacterial trade names, the more consumption of antibacterials: a European study. Clin Infect Dis (2005) 0.86

Structure--activity study of the antibacterial peptide fallaxin. Protein Sci (2007) 0.85

Prevalence of sulphonamide resistance and class 1 integron genes in Escherichia coli isolates obtained from broilers, broiler meat, healthy humans and urinary infections in Denmark. Int J Antimicrob Agents (2008) 0.85

Extended-spectrum β-lactamase (ESBL) in Danish clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence, β-lactamase distribution, phylogroups, and co-resistance. Scand J Infect Dis (2012) 0.85

Persisting clones of Escherichia coli isolates from recurrent urinary tract infection in men and women. J Med Microbiol (2010) 0.85

Novel polymyxin derivatives are effective in treating experimental Escherichia coli peritoneal infection in mice. J Antimicrob Chemother (2010) 0.84

The effect of S. pneumoniae bacteremia on cerebral blood flow autoregulation in rats. J Cereb Blood Flow Metab (2007) 0.84

Laboratory-based survey of dermatophyte infections in Denmark over a 10-year period. Acta Derm Venereol (2008) 0.84

Emergence of extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae in Danish hospitals; this is in part explained by spread of two CTX-M-15 clones with multilocus sequence types 15 and 16 in Zealand. Int J Antimicrob Agents (2011) 0.84

Plectasin shows intracellular activity against Staphylococcus aureus in human THP-1 monocytes and in a mouse peritonitis model. Antimicrob Agents Chemother (2009) 0.83

Evaluation of anti-pneumococcal capsular antibodies as adjunctive therapy in experimental pneumococcal meningitis. J Antimicrob Chemother (2006) 0.83

Report of the first human case of Caulobacter sp. infection. J Clin Microbiol (2007) 0.83

Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin. J Antimicrob Chemother (2010) 0.82

Intra- and extracellular activities of dicloxacillin against Staphylococcus aureus in vivo and in vitro. Antimicrob Agents Chemother (2010) 0.82

Evaluation of ROSCO Neo-Sensitabs for phenotypic detection and subgrouping of ESBL-, AmpC- and carbapenemase-producing Enterobacteriaceae. APMIS (2012) 0.82

Beta-hemolytic streptococcal bacteremia: a review of 241 cases. Scand J Infect Dis (2002) 0.82

Influence of antidrug antibodies on plectasin efficacy and pharmacokinetics. Antimicrob Agents Chemother (2009) 0.81